John D. Halpern - Dec 2, 2022 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Role
10%+ Owner
Signature
/s/ John D. Halpern
Stock symbol
ERNA
Transactions as of
Dec 2, 2022
Transactions value $
$1,185,798
Form type
4
Date filed
12/5/2022, 05:05 PM
Previous filing
May 19, 2021
Next filing
Jan 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ERNA Common Stock Purchase $1.1M +336K +292% $3.28 451K Dec 2, 2022 As trustee of family trust F1, F3, F4
holding ERNA Common Stock 205 Dec 2, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERNA Warrants (Right to Purchase) Purchase $84K +672K $0.13* 672K Dec 2, 2022 Common Stock 672K $3.28 As trustee of family trust F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

John D. Halpern is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Reflects a 1-for-20 reverse stock split effective October 17, 2022.
F2 Held by John D. Halpern
F3 Each share was purchased as part of a unit consisting of one share and two warrants, for a total purchase price of $3.53 per unit.
F4 The reporting persons disclaim beneficial ownership of these shares except to the extent of their pecuniary interest therein, if any.
F5 The exercisability of the Warrants is subject to a 9.99% beneficial ownership limitation.